Ophthalmology market research reports by China Research and Intelligence Co., Ltd.

Investigation Report on China's Aflibercept Market 2022-2031

Jul 25, 2022  |  Published by: China Research and Intelligence Co., Ltd.  |  USD 3,200

Investigation Report on China's Aflibercept Market 2022-2031 Aflibercept is an anti-VEGF drug, mainly used to treat neovascular age-related macular degeneration (wAMD), and other retinopathy caused by visual impairment. Aflibercept was jointly developed by Regeneron and Bayer. Regeneron has exclusiv ... Read More